Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,559,052
-$3,773,292 QoQ
Shares Held
36,546
-66.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#211
of 712 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jain Global LLC holds $69,700,158 across 7 Drug Manufacturers - General names. SNY ranks #5 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
197,926 | $49,806,098 | |
| 2 | LLY |
ELI LILLY & Co
|
9,899 | $11,873,158 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,975 | $3,209,287 | |
| 4 | AZN |
Astrazeneca PLC
|
8,660 | $1,642,109 | |
| 5 | SNY |
Sanofi
This page
|
36,546 | $1,559,052 | |
| 6 | GSK |
GSK plc
|
16,545 | $867,288 | |
| 7 | NVS |
Novartis AG
|
4,742 | $743,166 |
All Filings in SNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,559,052 | 36,546 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $5,332,344 | 110,036 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,269,859 | 132,836 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $1,342,819 | 27,842 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||